Today: 3 July 2026
Browse Category

Stock Market 5 January 2026

Intuit stock edges up after Jefferies flags TurboTax owner as 2026 software pick

Intuit stock edges up after Jefferies flags TurboTax owner as 2026 software pick

New York, Jan 5, 2026, 12:38 EST — Regular session Intuit Inc. shares rose 0.9% to $634.97 on Monday, recovering from an early dip, after Jefferies analyst Brent Thill singled out the TurboTax and QuickBooks owner as one of his preferred large-cap software names for 2026. Thill told investors to “stay underweight” software — meaning hold less than a benchmark allocation — while making exceptions for a short list that included Intuit, according to MarketWatch. MarketWatch
5 January 2026
·
Why Exxon Mobil stock is up today: Venezuela shock lifts XOM as oil prices firm

Why Exxon Mobil stock is up today: Venezuela shock lifts XOM as oil prices firm

New York, January 5, 2026, 12:39 PM EST — Regular session Exxon Mobil Corp shares rose about 2% to $125.08 in midday trading on Monday, as energy stocks gained after U.S. forces captured Venezuelan President Nicolas Maduro over the weekend. Analysts at J.P. Morgan said the upheaval could improve the odds Exxon recovers arbitration damages — compensation ordered by an arbitration panel after a legal dispute — tied to assets seized in 2007. Reuters
5 January 2026
····
GE Vernova stock today: Jan. 28 earnings date set as Vietnam LNG plant starts operations

GE Vernova stock today: Jan. 28 earnings date set as Vietnam LNG plant starts operations

New York, January 5, 2026, 12:22 EST — Regular session GE Vernova Inc shares slipped on Monday after the power-equipment maker scheduled its fourth-quarter and full-year results for Jan. 28. The stock was down 0.7% at $674.74 by 12:22 p.m. EST, after trading between $669.84 and $698.00. GE Vernova said it will release results before the market opens and host a webcast at 7:30 a.m. ET. GE Vernova
5 January 2026
··
1 … 890 891 892 893 894 … 1,613

Stock Market Today

  • AbbVie Jumps 4%, Tops Apogee Buy Price After Earnings Beat
    July 2, 2026, 7:16 PM EDT. AbbVie Inc. finished up 3.99% at $261.07, a new 52-week high. The stock gained nearly $17.8 billion in market cap, putting it well above the $10.9 billion Apogee Therapeutics deal announced June 22. AbbVie closed above targets from RBC Capital, Investing.com and Google Finance. With Q2 earnings set for July 31, the rally puts the spotlight on analyst target hikes. J.P. Morgan and RBC Capital have backed the Apogee buy for its long-term growth, with the company saying the acquisition will add to EPS by 2032. AbbVie outpaced broader markets, which slipped slightly, as investors bet on the drugmaker's deal strategy.
Go toTop